1. Dr. Bai-Chuang Hsu has been appointed Adjunct Research Fellow of the Institute of Biomedical Sciences, effective from July 1, 2023 to July 31, 2024.
  2. Dr. Teng-Nan Lin has been appointed Adjunct Research Fellow of the Institute of Biomedical Sciences, effective from August 1, 2023 to July 31, 2024.
  3. Dr. Kuo-Fang Chung has been promoted to Research Fellow of the Biodiversity Research Center, effective from June 5, 2023 to October 31, 2036.
  4. Dr. Jun-An Chen has been promoted to Research Fellow of the Institute of Molecular Biology, effective from June 5, 2023 to August 31, 2040.
  5. Dr. Yueh-Po Huang has been promoted to Associate Research Fellow of the Institute of Ethnology, effective from May 31, 2023 to September 30, 2035.
  6. Dr. Chuan Ku has been promoted to Associate Research Fellow of the Institute of Plant and Microbial Biology, effective from June 5, 2023 to November 30, 2052.
  7. Dr. Wendy W., Hwang-Verslues has been promoted to Associate Research Fellow of the Genomics Research Center, effective from June 5, 2023 to May 31, 2042.
  8. Dr. Guey-Shin Wang has been appointed Tenured Associate Research Fellow of the Institute of Biomedical Sciences, effective from August 1, 2023 to May 31, 2029.
  9. Dr. Jian-Geng Chiou has been appointed Assistant Research Fellow of the Institute of Plant and Microbial Biology, effective from SSeptember 15, 2023 to July 31, 2029.
  10. Dr. Hsun Chang, Research Fellow of the Institute of Ethnology, has been re-appointed Director of the Institute, effective from July 1, 2023 to June 30, 2024.
  11. Dr. Chung-Li Wu, Research Fellow of the Institute of Political Science, has been re-appointed Director of the Institute, effective from August 1, 2023 to July 31, 2026.
  12. Dr. Hwai-Jong Cheng, Distinguished Research Fellow of the Institute of Molecular Biology, has been re-appointed Director of the Institute, effective from July 27, 2023 to July 26, 2026.
  13. Dr. Shu-Ming Chung, Research Fellow of the Institute of Taiwan History, has been appointed Director of the Institute, effective from September 1, 2023 to June 30, 2025.
  14. Dr. Ying-Chih Chang, Research Fellow of the Genomics Research Center, has been re-seconded as Chief Executive Officer of Acrocyte Therapeutics Inc., effective from June1, 2023 to May 31, 2024.